{"id":"W2492626689","doi":"10.1007/s10637-016-0377-0","title":"A phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors","year":2016,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; GlaxoSmithKline","keywords":"Dosing; Tolerability; Trametinib; Medicine; Adverse effect; Rash; MEK inhibitor; Pharmacokinetics; Cohort; Internal medicine; Pharmacology; Oncology; Gastroenterology; MAPK/ERK pathway; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000266923,0.0002051506,0.0001921616,0.00008451389,0.00007030254,0.00001761395,0.0002545374,0.00008311046,0.000008850568],"category_scores_gemma":[0.0001696986,0.0001082942,0.00003738605,0.0003896534,0.000255868,0.00003239587,0.00005860092,0.0001339158,0.000001705928],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009413906,"about_ca_system_score_gemma":0.0004161275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006907761,"about_ca_topic_score_gemma":0.0003489409,"domain_scores_codex":[0.9982473,0.0001874722,0.0004143411,0.0003845432,0.0005584452,0.0002079526],"domain_scores_gemma":[0.998961,0.00009370389,0.0003339279,0.0003269015,0.0002075279,0.00007688926],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.004910308,0.006065147,0.4784087,0.00005608032,0.000170992,0.000003724952,0.006464698,0.005052131,0.4810009,0.0004050884,0.001778117,0.01568411],"study_design_scores_gemma":[0.05311109,0.007119237,0.579546,0.0007140508,0.00005467164,0.000002621312,0.0009278695,0.0001632663,0.3560338,0.0009201916,0.0007981262,0.0006091247],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972736,0.00002868213,0.00008754308,0.0013541,0.000109454,0.00107057,0.00002750899,0.000009008972,0.00003951934],"genre_scores_gemma":[0.9990642,0.000001372139,0.0002833061,0.0002258473,0.0001188562,0.0001203844,0.00004926307,0.0000294475,0.0001073442],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1249672,"threshold_uncertainty_score":0.4416111,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007907842871237351,"score_gpt":0.248194676809058,"score_spread":0.2402868339378207,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}